{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:17:53Z","timestamp":1790698673886,"version":"4.1.0"},"reference-count":26,"publisher":"Society of Nuclear Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.2967\/jnumed.122.265025","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T23:25:14Z","timestamp":1675985114000},"page":"902-909","source":"Crossref","is-referenced-by-count":33,"title":["<sup>68<\/sup>Ga-PSMA PET\/CT\u2013Based Atlas for Prostate Bed Recurrence After Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines"],"prefix":"10.2967","volume":"64","author":[{"given":"Ida","family":"Sonni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Dal Pra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan P.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Ells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Benz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickolas G.","family":"Nickols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minsong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar U.","family":"Kishan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremie","family":"Calais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"key":"2023060112150626000_64.6.902.1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj190"},{"key":"2023060112150626000_64.6.902.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.4.433"},{"key":"2023060112150626000_64.6.902.3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.8525"},{"key":"2023060112150626000_64.6.902.4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41585-021-00497-7","article-title":"Salvage therapy for prostate cancer after radical prostatectomy","volume":"18","author":"Zaorsky","year":"2021","journal-title":"Nat Rev Urol."},{"key":"2023060112150626000_64.6.902.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.02.006"},{"key":"2023060112150626000_64.6.902.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2007.07.017"},{"key":"2023060112150626000_64.6.902.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2008.05.006"},{"key":"2023060112150626000_64.6.902.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.04.068"},{"key":"2023060112150626000_64.6.902.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.10.097"},{"key":"2023060112150626000_64.6.902.10","first-page":"11N","volume":"62","author":"FDA approves first PSMA-targeted PET drug","year":"2021","journal-title":"J Nucl Med."},{"key":"2023060112150626000_64.6.902.11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.euo.2021.01.007","article-title":"Use and impact of positron emission tomography\/computed tomography prior to salvage radiation therapy in men with biochemical recurrence after radical prostatectomy: a scoping review","volume":"4","author":"Valle","year":"2021","journal-title":"Eur Urol Oncol."},{"key":"2023060112150626000_64.6.902.12","doi-asserted-by":"publisher","DOI":"10.1021\/bc200279b"},{"key":"2023060112150626000_64.6.902.13","first-page":"797","article-title":"Impact of patient weight and emission scan duration on PET\/CT image quality and lesion detectability","volume":"45","author":"Halpern","year":"2004","journal-title":"J Nucl Med."},{"key":"2023060112150626000_64.6.902.14","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","article-title":"68Ga-PSMA PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging\u2014version 1.0","volume":"44","author":"Fendler","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023060112150626000_64.6.902.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.198119"},{"key":"2023060112150626000_64.6.902.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2012.05.001"},{"key":"2023060112150626000_64.6.902.17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13014-020-01733-x","article-title":"Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techniques","volume":"16","author":"Rowe","year":"2021","journal-title":"Radiat Oncol."},{"key":"2023060112150626000_64.6.902.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.201749"},{"key":"2023060112150626000_64.6.902.19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.eururo.2021.05.033","article-title":"Dose-intensified versus conventional-dose salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: the SAKK 09\/10 randomized phase 3 trial","volume":"80","author":"Ghadjar","year":"2021","journal-title":"Eur Urol."},{"key":"2023060112150626000_64.6.902.20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijrobp.2019.09.047","article-title":"Toxicity and biochemical outcomes of dose-intensified postoperative radiation therapy for prostate cancer: results of a randomized phase III trial","volume":"106","author":"Qi","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2023060112150626000_64.6.902.21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijrobp.2022.05.044","article-title":"Mapping of local recurrences after radical prostatectomy using 68-gallium-prostate-specific membrane antigen positron emission tomography\/computed tomography: implications for postprostatectomy radiation therapy clinical target volumes","volume":"115","author":"Horsley","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2023060112150626000_64.6.902.22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijrobp.2021.12.174","article-title":"Adherence to contouring and treatment planning requirements within a multicentric trial: results of the quality assurance of the SAKK 09\/10 trial","volume":"113","author":"Beck","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2023060112150626000_64.6.902.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.035774"},{"key":"2023060112150626000_64.6.902.24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/j.semnuclmed.2021.11.013","article-title":"Recent advancements in CT and MR imaging of prostate cancer","volume":"52","author":"Daryanani","year":"2022","journal-title":"Semin Nucl Med."},{"key":"2023060112150626000_64.6.902.25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.euf.2020.12.009","article-title":"Update from PSMA-SRT trial NCT03582774: a randomized phase 3 imaging trial of prostate-specific membrane antigen positron emission tomography for salvage radiation therapy for prostate cancer recurrence powered for clinical outcome","volume":"7","author":"Calais","year":"2021","journal-title":"Eur Urol Focus."},{"key":"2023060112150626000_64.6.902.26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00259-022-05931-5","article-title":"The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy: a multicenter retrospective analysis","volume":"50","author":"Spohn","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.122.265025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T19:19:12Z","timestamp":1685647152000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.122.265025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6,1]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.2967\/jnumed.122.265025"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.122.265025","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]}}}